The Food and Drug Administration awarded a $947,034 definitive contract to Barco, Inc. for advanced physical and digital slides for characterization, performance, and interoperability assessment of digital pathology systems on September 30, 2026, under EO 14398 as a firm fixed-price award with no set-aside.
The originating solicitation is the FY26 FDA Broad Agency Announcement for Advanced Research and Development of Regulatory Science, posted November 21, 2025, with amendments through January 16, 2026. The BAA solicits basic and applied research and development proposals supporting regulatory science and innovation across FDA-regulated domains, with particular focus on modernizing product development and evaluation, strengthening post-market surveillance and labeling, and advancing public health preparedness. Eligible offerors include private sector organizations, FFRDCs, and academic institutions. Place of performance is Johns Creek, Georgia. The contract extends through June 29, 2028.